Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin

NCT00563732 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Lecozotan

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer